Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker
NCT02848066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 353
Last updated 2019-05-20
Summary
The purpose of this study is to evaluate sensitivity and specificity of newly defined tumor biomarker with gastric cancer pts and cancer-free healthy volunteers.
Conditions
Interventions
- PROCEDURE
-
Blood sample(10cc) collection
In both groups, serum haptoglobins to be collected and analyzed
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-08-31
- Completion
- 2017-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric Cancer
NCT07096752 ·Status: NOT_YET_RECRUITING
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Gastric Cancer Marker Detection and Its Kit Development
NCT05010863 ·Status: RECRUITING
-
Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer
NCT06023121 ·Status: COMPLETED
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Use of Blood Biomarkers to Predict Gastric Cancer Risk
NCT04329299 ·Status: COMPLETED
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING
-
Early Detection and Post-operative Monitoring of Gastric Cancer
NCT06232395 ·Status: RECRUITING
-
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
NCT01004887 ·Status: COMPLETED
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-Gastric
NCT05224596 ·Status: UNKNOWN
-
Glycosaminoglycan Scores as Monitoring Biomarkers in Confined Renal Cell Carcinoma
NCT02732652 ·Status: COMPLETED
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma
NCT02732665 ·Status: COMPLETED
-
Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood
NCT06544083 ·Status: RECRUITING
-
The Samsung Medical Center Comprehensive Cancer Center Registry from 2008 to 2023
NCT06703957 ·Status: COMPLETED
-
Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer
NCT04947995 ·Status: UNKNOWN
-
Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer
NCT03076567 ·Status: COMPLETED
-
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer
NCT05513144 ·Status: UNKNOWN
-
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection
NCT05901376 ·Status: UNKNOWN
-
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
NCT01482520 ·Status: COMPLETED
-
Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer
NCT07092397 ·Status: COMPLETED
-
Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer
NCT05991947 ·Status: RECRUITING
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
Biomarker Research for Personalized Medicine
NCT01488591 ·Status: UNKNOWN
-
Characterization of Tissue Biochemical Composition in Gastric Precancerous/Cancerous Lesions
NCT05977478 ·Status: UNKNOWN ·Phase: NA